{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:24:25Z","timestamp":1762917865004,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00198-018-4467-z","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T02:09:39Z","timestamp":1521684579000},"page":"1437-1445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predicting mortality and incident immobility in older Belgian men by characteristics related to sarcopenia and frailty"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5590-2245","authenticated-orcid":false,"given":"C.","family":"Kruse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Goemaere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"De Buyser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lapauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Eiken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"issue":"3","key":"4467_CR1","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146\u2013M156","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"4467_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-jentoft","year":"2010","unstructured":"Cruz-jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412\u2013423","journal-title":"Age Ageing"},{"key":"4467_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12877-015-0171-4","volume":"15","author":"HP Patel","year":"2015","unstructured":"Patel HP, White MC, Westbury L, Syddall HE, Stephens PJ, Clough GF, Cooper C, Sayer AA (2015) Skeletal muscle morphology in sarcopenia defined using the EWGSOP criteria: findings from the Hertfordshire Sarcopenia Study (HSS). BMC Geriatr 15:171","journal-title":"BMC Geriatr"},{"issue":"2","key":"4467_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/gerona\/glv129","volume":"71","author":"L Bianchi","year":"2016","unstructured":"Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, Brombo G, Zuliani G, Guralnik JM, Landi F, Volpato S (2016) The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 71(2):259\u2013264","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"4467_CR5","doi-asserted-by":"crossref","unstructured":"De Buyser SL, Petrovic M, Taes YE, et al (2016) Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. Age Ageing","DOI":"10.1093\/ageing\/afw071"},{"issue":"11","key":"4467_CR6","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/jgs.13788","volume":"63","author":"PM Cawthon","year":"2015","unstructured":"Cawthon PM, Blackwell TL, Cauley J, Kado DM, Barrett-Connor E, Lee CG, Hoffman AR, Nevitt M, Stefanick ML, Lane NE, Ensrud KE, Cummings SR, Orwoll ES (2015) Evaluation of the usefulness of consensus definitions of sarcopenia in older men: results from the observational osteoporotic fractures in men cohort study. J Am Geriatr Soc 63(11):2247\u20132259","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"4467_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1532-5415.2005.00586.x","volume":"54","author":"TM Gill","year":"2006","unstructured":"Gill TM, Allore HG, Hardy SE, Guo Z (2006) The dynamic nature of mobility disability in older persons. J Am Geriatr Soc 54(2):248\u2013254","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"4467_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2265.2008.03365.x","volume":"70","author":"G Vanbillemont","year":"2009","unstructured":"Vanbillemont G, Bogaert V, De bacquer D et al (2009) Polymorphisms of the SHBG gene contribute to the interindividual variation of sex steroid hormone blood levels in young, middle-aged and elderly men. Clin Endocrinol 70(2):303\u2013310","journal-title":"Clin Endocrinol"},{"issue":"3","key":"4467_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1530\/EJE-06-0607","volume":"156","author":"B Lapauw","year":"2007","unstructured":"Lapauw B, Goemaere S, Crabbe P, Kaufman JM, Ruige JB (2007) Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men? Eur J Endocrinol 156(3):395\u2013401","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"4467_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1530\/EJE-07-0873","volume":"159","author":"B Lapauw","year":"2008","unstructured":"Lapauw B, Goemaere S, Zmierczak H, van Pottelbergh I, Mahmoud A, Taes Y, de Bacquer D, Vansteelandt S, Kaufman JM (2008) The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes. Eur J Endocrinol 159(4):459\u2013468","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"4467_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2265.1999.00741.x","volume":"51","author":"JK Saffele Van den","year":"1999","unstructured":"Van den Saffele JK, Goemaere S, De Bacquer D, Kaufman JM (1999) Serum leptin levels in healthy ageing men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency? Clin Endocrinol 51(1):81\u201388","journal-title":"Clin Endocrinol"},{"issue":"2","key":"4467_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S (1991) The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142\u2013148","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"4467_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1532-5415.1982.tb02835.x","volume":"30","author":"MW Linn","year":"1982","unstructured":"Linn MW, Linn BS (1982) The rapid disability rating scale-2. J Am Geriatr Soc 30(6):378\u2013382","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"4467_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I Conceptual framework and item selection. Med Care 30(6):473\u2013483","journal-title":"Med Care"},{"key":"4467_CR15","unstructured":"Kuhn M (2008) Building Predictive Models in R Using the caret Package. J Statist Softw 28(5):1\u201326"},{"issue":"1","key":"4467_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32\u201335","journal-title":"Cancer"},{"issue":"4","key":"4467_CR17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1365-2656.2008.01390.x","volume":"77","author":"J Elith","year":"2008","unstructured":"Elith J, Leathwick JR, Hastie T (2008) A working guide to boosted regression trees. J Anim Ecol 77(4):802\u2013813","journal-title":"J Anim Ecol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4467-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4467-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4467-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T20:31:57Z","timestamp":1553200317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4467-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4467"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4467-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"16 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CK has received travel grants from Eli Lilly, Otsuka Pharmaceutical and is a speaker for Novartis and Otsuka Pharmaceutical. PE is an advisory board member with Amgen, MSD, and Eli Lilly and at the speaker\u2019s bureau with Amgen and Eli Lilly, stocks from Novo Nordisk A\/S. PV has received unrestricted grants from MSD and Servier, and travel grants from Amgen, Eli Lilly, Novartis, Sanofi-Aventis, and Servier.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}